StreetInsider.com News Articles

McKesson (MCK) Raises Quarterly Dividend 14.6% to $0.94; 0.5% Yield

Wed, 22 Jul 2026 08:03:36 -0400

McKesson (NYSE: MCK) declared a quarterly dividend of $0.94 per share, or $3.76 annualized. This is a 14.6% increase from the prior dividend of $0.82.

The dividend will be payable on October 1, 2026, to stockholders of record on September 1, 2026, with an ex-dividend date of August 31, 2026.

The annual yield on the dividend is 0.5 percent.

For a dividend history and other dividend-related data on McKesson (MCK) click here.

McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

Wed, 22 Jul 2026 08:00:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable on October 1, 2026, to shareholders of record on September 1, 2026.

“Today’s announcement marks our tenth consecutive year of dividend growth, reflecting the strength of our business, our disciplined approach to capital allocation and our commitment to returning capital to shareholders,” said Brian Tyler, chair and chief executive officer. “We remain focused on leveraging our financial strength to

McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

Wed, 22 Jul 2026 08:00:00 -0400

McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

Wed, 22 Jul 2026 08:00:00 -0400

McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

Wed, 22 Jul 2026 08:00:00 -0400

McKesson (MCK) PT Raised to $955 at Baird

Wed, 22 Jul 2026 06:21:41 -0400

Baird analyst Eric Coldwell raised the price target on McKesson (NYSE: MCK) to $955.00 (from $941.00) while maintaining a Outperform rating.

McKesson (MCK) PT Lowered to $989 at TD Cowen

Tue, 21 Jul 2026 07:54:53 -0400

TD Cowen analyst Charles Rhyee lowered the price target on McKesson (NYSE: MCK) to $989.00 (from $1,012.00) while maintaining a rating.

Form 4 MCKESSON CORP For: Jul 07 Filed by: TYLER BRIAN S.

Wed, 08 Jul 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260708/26747852.html

Form 4 MCKESSON CORP For: Jul 07 Filed by: TYLER BRIAN S.

Wed, 08 Jul 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260708/26747852.html

Form 144 MCKESSON CORP Filed by: TYLER BRIAN S.

Tue, 07 Jul 2026 09:46:00 -0400

si-local-file:///var/storage/secattach/20260707/26739998.html

Form 144 MCKESSON CORP Filed by: TYLER BRIAN S.

Tue, 07 Jul 2026 09:46:00 -0400

si-local-file:///var/storage/secattach/20260707/26739998.html

Form 8-K MCKESSON CORP For: Jun 29

Wed, 01 Jul 2026 08:03:00 -0400

si-local-file:///var/storage/secattach/20260701/26717192.html

Form 8-K MCKESSON CORP For: Jun 29

Wed, 01 Jul 2026 08:03:00 -0400

si-local-file:///var/storage/secattach/20260701/26717192.html

Form DEFA14A MCKESSON CORP

Tue, 30 Jun 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260630/26714206.html

Form DEFA14A MCKESSON CORP

Tue, 30 Jun 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260630/26714206.html

McKesson (MCK) PT Lowered to $60 at TD Cowen

Fri, 26 Jun 2026 08:05:09 -0400

TD Cowen analyst Charles Rhyee lowered the price target on McKesson (NYSE: MCK) to $60.00 (from $64.00) while maintaining a Buy rating.

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

Wed, 24 Jun 2026 08:00:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

The live and archived audio webcast will be available on McKesson’s Investor Relations website.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

Wed, 24 Jun 2026 08:00:00 -0400

The live and archived audio webcast will be available on McKesson’s Investor Relations website.

About McKesson Corporation

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

Wed, 24 Jun 2026 08:00:00 -0400

The live and archived audio webcast will be available on McKesson’s Investor Relations website.

About McKesson Corporation

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

Wed, 24 Jun 2026 08:00:00 -0400

The live and archived audio webcast will be available on McKesson’s Investor Relations website.

About McKesson Corporation

Form 4 MCKESSON CORP For: Jun 17 Filed by: TYLER BRIAN S.

Thu, 18 Jun 2026 15:36:00 -0400

si-local-file:///var/storage/secattach/20260618/26665646.html

Form 4 MCKESSON CORP For: Jun 17 Filed by: TYLER BRIAN S.

Thu, 18 Jun 2026 15:36:00 -0400

si-local-file:///var/storage/secattach/20260618/26665646.html

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

Investing.com -- Oral Wegovy accounted for approximately 33% of total Wegovy prescriptions in May, according to a Bank of America report released Thursday. The oral formulation reached 159,000 weekly total prescriptions in the week ending June 5, 2026.

The oral version of Wegovy launched in early January and has grown rapidly since its introduction. Weekly new prescriptions for oral Wegovy represented 40% of total new Wegovy prescriptions in the week ending June 5, 2026. The mix of oral prescriptions has stabilized in the low-30% range over recent weeks after initial rapid growth.

The broader GLP-1 drug category showed weekly total prescription growth

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

The broader GLP-1 drug category showed weekly total prescription growth

Oral Wegovy reaches 33% of total prescriptions by May

Thu, 18 Jun 2026 05:47:49 -0400

The broader GLP-1 drug category showed weekly total prescription growth